scholarly journals Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery using automated planning

2020 ◽  
Author(s):  
Chengqiang Li ◽  
Cheng Tao ◽  
Tong Bai ◽  
Zhenjiang Li ◽  
Ying Tong ◽  
...  

Abstract Background: To investigate the beam complexity and monitor unit(MU)efficiency issues for two different volumetric modulated arc therapy (VMAT) delivery technologies for patients with left-sided breast cancer (BC) and nasopharyngeal carcinoma (NPC). Methods: Twelve left-sided BC and seven NPC cases were enrolled in this study. Each delivered treatment plan was optimized in Pinnacle 3 treatment planning system with Auto-Planning module for Trilogy and Synergy systems. Similar planning dose objectives and beam configuration were used for each site in two different delivery systems to produce clinically acceptable plans. Beam complexity was evaluated in terms of segment area(SA), segment width(SW), leaf sequence variability(LSV), aperture area variability(AAV), modulation complexity score(MCS) based on MLC sequence and MU. Results: With similar plan quality, the average SAs for Trilogy plans were smaller than those for Synergy plans: 55.5 ± 21.3 cm 2 vs. 66.3 ± 17.9 cm 2 (p<0.05) for the NPC cases, and 100.7 ± 49.2 cm 2 vs. 108.5 ± 42.7 cm 2 (p<0.05) for BC cases, respectively. The SW was statistically significant for two delivery systems (NPC: 6.87±1.95cm vs.6.72±2.71cm, p < 0.05; BC: 8.84±2.56cm vs.8.09±2.63cm, p < 0.05). LSV was statistically significant smaller for Trilogy (NPC: 0.84±0.033 vs.0.86±0.033, p < 0.05; BC: 0.89±0.026 vs.0.90±0.26, p < 0.05). The mean AAV was statistically significant larger for Trilogy than Synergy (NPC: 0.18±0.064 vs.0.14±0.037, p < 0.05; BC: 0.46±0.15 vs.0.33±0.13, p < 0.05). The MCS values for the Trilogy were higher than those for the Synergy: 0.14 ± 0.016vs. 0.12 ± 0.017 (p<0.05) for the NPC cases, and 0.42 ± 0.106 vs. 0.30 ± 0.087(p<0.05) for the BC cases. Compared with Synergy plans, the average MU for Trilogy plans were larger: 828.6±74.1MU and 782.9±85.2MU (p>0.05) for the NPC cases, and 444.8±61.3MU and 393.8±75.3MU (p>0.05) for the BC cases. Conclusions: The pinnacle 3 Auto planning system can optimize BC and NPC plans to obtain the same plan quality using Trilogy and Synergy systems. We found that this two systems resulted in different SA, SW, LSV, AAV and MCS. As a result, we suggested that beam complexity should be considered in providing further methodologies while optimizing VMAT auto planning.

2020 ◽  
Author(s):  
Chengqiang Li ◽  
Cheng Tao ◽  
Tong Bai ◽  
Zhenjiang Li ◽  
Ying Tong ◽  
...  

Abstract Background: To investigate the beam complexity and monitor unit(MU)efficiency issues for two different volumetric modulated arc therapy (VMAT) delivery technologies for patients with left-sided breast cancer (BC) and nasopharyngeal carcinoma (NPC). Methods: Twelve left-sided BC and seven NPC cases were enrolled in this study. Each delivered treatment plan was optimized in Pinnacle 3 treatment planning system with Auto-Planning module for Trilogy and Synergy systems. Similar planning dose objectives and beam configuration were used for each site in two different delivery systems to produce clinically acceptable plans. Beam complexity was evaluated in terms of segment area(SA), segment width(SW), leaf sequence variability(LSV), aperture area variability(AAV), modulation complexity score(MCS) based on MLC sequence and MU. Results: With similar plan quality, the average SAs for Trilogy plans were smaller than those for Synergy plans: 55.5 ± 21.3 cm 2 vs. 66.3 ± 17.9 cm 2 (p<0.05) for the NPC cases, and 100.7 ± 49.2 cm 2 vs. 108.5 ± 42.7 cm 2 (p<0.05) for BC cases, respectively. The SW was statistically significant for two delivery systems (NPC: 6.87±1.95cm vs.6.72±2.71cm, p < 0.05; BC: 8.84±2.56cm vs.8.09±2.63cm, p < 0.05). LSV was statistically significant smaller for Trilogy (NPC: 0.84±0.033 vs.0.86±0.033, p < 0.05; BC: 0.89±0.026 vs.0.90±0.26, p < 0.05). The mean AAV was statistically significant larger for Trilogy than Synergy (NPC: 0.18±0.064 vs.0.14±0.037, p < 0.05; BC: 0.46±0.15 vs.0.33±0.13, p < 0.05). The MCS values for the Trilogy were higher than those for the Synergy: 0.14 ± 0.016vs. 0.12 ± 0.017 (p<0.05) for the NPC cases, and 0.42 ± 0.106 vs. 0.30 ± 0.087(p<0.05) for the BC cases. Compared with Synergy plans, the average MU for Trilogy plans were larger: 828.6±74.1MU and 782.9±85.2MU (p>0.05) for the NPC cases, and 444.8±61.3MU and 393.8±75.3MU (p>0.05) for the BC cases. Conclusions: The pinnacle 3 Auto planning system can optimize BC and NPC plans to obtain the same plan quality using Trilogy and Synergy systems. We found that this two systems resulted in different SA, SW, LSV, AAV and MCS. As a result, we suggested that beam complexity should be considered in providing further methodologies while optimizing VMAT auto planning.


BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Chengqiang Li ◽  
Cheng Tao ◽  
Tong Bai ◽  
Zhenjiang Li ◽  
Ying Tong ◽  
...  

Abstract Background To investigate the beam complexity and monitor unit (MU) efficiency issues for two different volumetric modulated arc therapy (VMAT) delivery technologies for patients with left-sided breast cancer (BC) and nasopharyngeal carcinoma (NPC). Methods Twelve left-sided BC and seven NPC cases were enrolled in this study. Each delivered treatment plan was optimized in the Pinnacle3 treatment planning system with the Auto-Planning module for the Trilogy and Synergy systems. Similar planning dose objectives and beam configurations were used for each site in the two different delivery systems to produce clinically acceptable plans. The beam complexity was evaluated in terms of the segment area (SA), segment width (SW), leaf sequence variability (LSV), aperture area variability (AAV), and modulation complexity score (MCS) based on the multileaf collimator sequence and MU. Plan delivery and a gamma evaluation were performed using a helical diode array. Results With similar plan quality, the average SAs for the Trilogy plans were smaller than those for the Synergy plans: 55.5 ± 21.3 cm2 vs. 66.3 ± 17.9 cm2 (p < 0.05) for the NPC cases and 100.7 ± 49.2 cm2 vs. 108.5 ± 42.7 cm2 (p < 0.05) for the BC cases, respectively. The SW was statistically significant for the two delivery systems (NPC: 6.87 ± 1.95 cm vs. 6.72 ± 2.71 cm, p < 0.05; BC: 8.84 ± 2.56 cm vs. 8.09 ± 2.63 cm, p < 0.05). The LSV was significantly smaller for Trilogy (NPC: 0.84 ± 0.033 vs. 0.86 ± 0.033, p < 0.05; BC: 0.89 ± 0.026 vs. 0.90 ± 0.26, p < 0.05). The mean AAV was significantly larger for Trilogy than for Synergy (NPC: 0.18 ± 0.064 vs. 0.14 ± 0.037, p < 0.05; BC: 0.46 ± 0.15 vs. 0.33 ± 0.13, p < 0.05). The MCS values for Trilogy were higher than those for Synergy: 0.14 ± 0.016 vs. 0.12 ± 0.017 (p < 0.05) for the NPC cases and 0.42 ± 0.106 vs. 0.30 ± 0.087 (p < 0.05) for the BC cases. Compared with the Synergy plans, the average MUs for the Trilogy plans were larger: 828.6 ± 74.1 MU and 782.9 ± 85.2 MU (p > 0.05) for the NPC cases and 444.8 ± 61.3 MU and 393.8 ± 75.3 MU (p > 0.05) for the BC cases. The gamma index agreement scores were never below 91% using 3 mm/3% (global) distance to agreement and dose difference criteria and a 10% lower dose exclusion threshold. Conclusions The Pinnacle3 Auto-Planning system can optimize BC and NPC plans to achieve the same plan quality using both the Trilogy and Synergy systems. We found that these two systems resulted in different SAs, SWs, LSVs, AAVs and MCSs. As a result, we suggested that the beam complexity should be considered in the development of further methodologies while optimizing VMAT autoplanning.


2018 ◽  
Vol 18 (03) ◽  
pp. 304-308
Author(s):  
Jalil ur Rehman ◽  
Zahra Syed ◽  
Ghulam Hussain ◽  
Nisar Ahmad ◽  
H M Noor ul Huda Khan Asghar ◽  
...  

AbstractPurposeTo verify dose delivery and quality assurance of volumetric-modulated arc therapy (VMAT) for head and neck (H&amp;N) cancer.MethodThe Imaging and Radiation Oncology Core Houston (IROC-H) H&amp;N phantom with thermoluminescent dosimeters (TLDs) and films, were imaged with computed tomography scan and the reconstructed image was transferred to pinnacle treatment planning system (TPS). On TPS, the planning target volume (PTV), secondary target volume (STV) and organ at risk (OAR) were delineated manually and a treatment plan was made. The dose constraints were determined for the concerned organs according to IROC-H prescription. The treatment plan was optimised using adoptive convolution algorithm to improve dose homogeneity and conformity. The dose calculation was performed using C.C Convolution algorithm and a Varian True Beam linear accelerator was used to deliver the treatment plan to the H&amp;N phantom. The delivered radiation dose to the phantom was measured through TLDs and GafChromic external beam radiotherapy 2 (EBT2) films. The dosimetric performance of the VMAT delivery was studied by analysing percent dose difference, isodose line profile and gamma analysis of the TPS-computed dose and linac-delivered doses.ResultThe percent dose difference of 3.8% was observed between the planned and measured doses of TLDs and a 1.5-mm distance to agreement (DTA) was observed by comparing isodose line profiles. Passed the gamma criteria of 3%/3 mm was with good percentages.ConclusionThe dosimetric performance of VMAT delivery for a challenging H&amp;N radiotherapy can be verified using TLDs and films embedded in an anthropomorphic H&amp;N phantom.


2018 ◽  
Vol 17 (4) ◽  
pp. 441-446 ◽  
Author(s):  
Jalil ur Rehman ◽  
Muhammad Isa ◽  
Nisar Ahmad ◽  
H. M. Noor ul Huda Khan Asghar ◽  
Zaheer A. Gilani ◽  
...  

AbstractBackgroundAccurate three-dimensional dosimetry is essential in modern radiotherapy techniques such as volumetric-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). In this research work, the PRESAGE® dosimeter was used as quality assurance (QA) tool for VMAT planning for head and neck (H&N) cancer.Material and methodComputer tomography (CT) scans of an Image Radiation Oncology Core (IROC) H&N anthropomorphic phantom with both IROC standard insert and PRESAGE® insert were acquired separately. Both CT scans were imported into the Pinnacle (9.4 version) TPS for treatment planning, where the structures [planning target volume (PTV), organs at risk) and thermoluminescent detectors (TLDs) were manually contoured and used to optimise a VMAT plan. Treatment planning was done using VMAT (dual arc: 182°–178°, 178°–182°). Beam profile comparisons and gamma analysis were used to quantify agreement with film, PRESAGE® measurement and treatment planning system (TPS) calculated dose distribution.ResultsThe average ratio of TLD measured to calculated doses at the four PTV locations in the H&N phantom were between 0·95 to 0·99 for all three VMAT deliveries. Dose profiles were taken along the left–right, the anterior–posterior and superior–inferior axes, and good agreement was found between the PRESAGE® and Pinnacle profile. The mean value of gamma results for three VMAT deliveries in axial and sagittal planes were found to be 94·24 and 93·16% when compared with film and Pinnacle, respectively. The average values comparing the PRESAGE® results and dose values calculated on Pinnacle were observed to be 95·29 and 94·38% in the said planes, respectively, using a 5%/3 mm gamma criteria.ConclusionThe PRESAGE® dose measurements and calculated dose of pinnacle show reasonable agreement in both axial and sagittal planes for complex dual arc VMAT treatment plans. In general, the PRESAGE® dosimeter is found to be a feasible QA tool of VMAT plan for H&N cancer treatment.


2015 ◽  
Vol 49 (3) ◽  
pp. 291-298 ◽  
Author(s):  
Christopher Amaloo ◽  
Daryl P. Nazareth ◽  
Lalith K. Kumaraswamy

Abstract Background. Volumetric modulated arc therapy (VMAT) has quickly become accepted as standard of care for the treatment of prostate cancer based on studies showing it is able to provide faster delivery with adequate target coverage and reduced monitor units while maintaining organ at risk (OAR) sparing. This study aims to demonstrate the potential to increase dose conformality with increased planner control and OAR sparing using a hybrid treatment technique compared to VMAT. Methods. Eleven patients having been previously treated for prostate cancer with VMAT techniques were replanned with a hybrid technique on Varian Treatment Planning System. Multiple static IMRT fields (2 to 3) were planned initially based on critical OAR to reduce dose but provide some planning treatment volume (PTV) coverage. This was used as a base dose plan to provide 30-35% coverage for a single arc VMAT plan. Results. The clinical VMAT plan was used as a control for the purposes of comparison. Average of all OAR sparing between the hybrid technique and VMAT showed the hybrid plan delivering less dose in almost all cases except for V80 of the bladder and maximum dose to right femoral head. PTV coverage was superior with the VMAT technique. Monitor unit differences varied, with the hybrid plan able to deliver fewer units 37% of the time, similar results 18% of the time, and higher units 45% of the time. On average, the hybrid plan delivered 10% more monitor units. Conclusions. The hybrid plan can be delivered in a single gantry rotation combining aspects of VMAT with regions of dynamic intensity modulated radiation therapy (IMRT) within the treatment arc.


2016 ◽  
Vol 58 (4) ◽  
pp. 579-590 ◽  
Author(s):  
Ghulam Murtaza ◽  
Stefania Cora ◽  
Ehsan Ullah Khan

Abstract Volumetric-modulated arc therapy (VMAT) is an efficient form of radiotherapy used to deliver intensity-modulated radiotherapy beams. The aim of this study was to investigate the relative insensitivity of VMAT plan quality to gantry angle spacing (GS). Most previous VMAT planning and dosimetric work for GS resolution has been conducted for single arc VMAT. In this work, a quantitative comparison of dose–volume indices (DIs) was made for partial-, single- and double-arc VMAT plans optimized at 2°, 3° and 4° GS, representing a large variation in deliverable multileaf collimator segments. VMAT plans of six prostate cancer and six head-and-neck cancer patients were simulated for an Elekta SynergyS® Linac (Elekta Ltd, Crawley, UK), using the SmartArc™ module of Pinnacle³ TPS, (version 9.2, Philips Healthcare). All optimization techniques generated clinically acceptable VMAT plans, except for the single-arc for the head-and-neck cancer patients. Plan quality was assessed by comparing the DIs for the planning target volume, organs at risk and normal tissue. A GS of 2°, with finest resolution and consequently highest intensity modulation, was considered to be the reference, and this was compared with GS 3° and 4°. The differences between the majority of reference DIs and compared DIs were &lt;2%. The metrics, such as treatment plan optimization time and pretreatment (phantom) dosimetric calculation time, supported the use of a GS of 4°. The ArcCHECK™ phantom–measured dosimetric agreement verifications resulted in a &gt;95.0% passing rate, using the criteria for γ (3%, 3 mm). In conclusion, a GS of 4° is an optimal choice for minimal usage of planning resources without compromise of plan quality.


2019 ◽  
Vol 19 (4) ◽  
pp. 393-398 ◽  
Author(s):  
Payal Raina ◽  
Sudha Singh ◽  
Rajanigandha Tudu ◽  
Rashmi Singh ◽  
Anup Kumar

AbstractAim:The aim of this study was to compare volumetric modulated arc therapy (VMAT) with dynamic intensity-modulated radiation therapy (dIMRT) and step-and-shoot IMRT (ssIMRT) for different treatment sites.Materials and methods:Twelve patients were selected for the planning comparison study. This included three head and neck, three brain, three rectal and three cervical cancer patients. Total dose of 50 Gy was given for all the plans. Plans were done for Elekta synergy with Monaco treatment planning system. All plans were generated with 6 MV photons beam. Plan evaluation was based on the ability to meet the dose volume histogram, dose homogeneity index, conformity index and radiation delivery time, and monitor unit needs to deliver the prescribed dose.Results:The VMAT and dIMRT plans achieved the better conformity (CI98% = 0·965 ± 0·023) and (CI98% = 0·939 ± 0·01), respectively, while ssIMRT plans were slightly inferior (CI98% = 0·901 ± 0·038). The inhomogeneity in the planning target volume (PTV) was highest with ssIMRT with HI equal to 0·097 ± 0·015 when compared to VMAT with HI equal to 0·092 ± 0·0369 and 0·095 ± 0·023 with dIMRT. The integral dose is found to be inferior with VMAT 105·31 ± 53·6 (Gy L) when compared with dIMRT 110·75 ± 52·9 (Gy L) and ssIMRT 115 38 ± 55·1(Gy L). All the techniques respected the planning objective for all organs at risk. The delivery time per fraction for VMAT was much lower than dIMRT and ssIMRT.Findings:Our results indicate that dIMRT and VMAT provide better sparing of normal tissue, homogeneity and conformity than ssIMRT with reduced treatment delivery time.


Sign in / Sign up

Export Citation Format

Share Document